Roche Diagnostics growth remains muted amid China headwinds
Roche’s Diagnostics division continues to battle growth headwinds, notching a 3% increase in sales.
The latest headlines across every section, pulled from official and open-access sources.
Roche’s Diagnostics division continues to battle growth headwinds, notching a 3% increase in sales.
Ahead of World Drowning Prevention Day on 25 July, the World Health Organization (WHO) is launching a new technical package to help governments and communities implement seven proven measures to reduce drowning deaths.
Australian biopharma Clinuvel Pharmaceuticals is moving its headquarters to the U.S.— but up to a fifth of the company’s workforce won’t be staying for the trans-Pacific pivot.
Assured Health raised $19 million for its AI agents that verify provider credentials and manage insurance enrollment for health systems and group practices. The startup said it can cut a process that usually takes months down to days. The post Assured Health Secures $19M to Get Providers In-Network Faster with Agentic AI appeared first on MedCity News .
Roche may have scrapped work on a T-cell engager being evaluated for lupus, but the company’s head of pharma told Fierce that still has a strategy for developing cell therapies for autoimmune diseases.
The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as the company looks to compete with Intuitive Surgical and Medtronic.
Midwest Poultry Services, L.P. is voluntarily recalling 1,589,577 dozen white shell eggs and brown cage free shell eggs produced in Texas because they have the potential to be contaminated with Salmonella Enteritidis. Salmonella is an organism which can cause serious and sometimes fatal infections i
Oncology
This cohort study examines rates of primary care follow-up within 14 days of a hospitalization for children with vs without medical complexity.
This cross-sectional study describes methods and timing of dissemination of the results of efficacy and safety trials outlined in postmarketing requirements for novel drugs approved by the US Food and Drug Administration (FDA).
This cross-sectional study seeks to quantify the association between minimum concentration and area under the concentration curve (AUC) measurements of vancomycin.
This survey study describes outcomes associated with patient and caregiver engagement in the prior authorization process.
This cohort study examines the prevalence of palliative care concurrent with cancer-directed therapy among adults ages 18 to 39 years with advanced cancer.
This cross-sectional study examines second-level appeals for denied anticancer medications in Medicare Part D to assess the quality of utilization management decisions.
This cohort study identifies the demographic and tumor characteristics, disease detection methods, and survival outcomes for transgender, nonbinary, and/or gender-diverse patients with stage 0 to IV breast cancer.
This cohort study assesses the association between height and regional injury patterns among children involved in motor vehicle crashes evaluated at trauma centers and examines how these patterns vary between child restraint system and seat belt users.
Thousands of people with multiple sclerosis (MS) in England are to be offered a new ‘signal booster’ therapy on the NHS to help them walk more easily and live more independently. Fampridine is the first medicine designed to improve walking in adults with MS and will now be routinely available on the NHS from today, […]
GSK drug Jideytro received FDA approval for treating advanced cases of non-small cell lung cancer driven by ROS1 alterations. This molecule came from Nuvalent, which GSK recently acquired for $10.6 billion. The post $10B M&A Deal Pays Off With GSK’s First Lung Cancer Drug Approval appeared first on MedCity News .
Headspace announced partnerships with Charlie Health, Cortica, Prosper Health and Equip. The post Headspace Teams Up with 4 Companies for Specialty Care appeared first on MedCity News .
Andrew Aberdale will help expand AiM’s strategic partnership ecosystem, including its recent collaboration with Siemens Healthineers, the company said.
Extending DAPT for an additional year reduced major adverse cardiovascular events (MACE) without increasing bleeding risk compared with aspirin alone among patients with multivessel coronary artery disease (MVCAD) who had no ischemic or bleeding events one year after PCI with a drug-eluting stent, according to results of the DAPT-MVD trial published July 15 in NEJM.
Ami Bhatt is joining the company as it makes a broader push into health.
Shareholders approved a plan to dissolve the robot developer, at one time a well-financed contender to challenge surgical robotics leader Intuitive, and liquidate its assets.
The ACC Board of Trustees (BOT) has approved the College's next slate of officers and new trustees, who will begin their terms in April 2027 following ACC's Annual Scientific Session in Houston, TX.